About: covid:PMC6925545

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC6925545 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
Creator	Bartoszewicz, Natalia Czyzewski, Krzysztof Demidowicz, Ewa Dziedzic, Magdalena Fraczkiewicz, Jowita Galazka, Przemyslaw Gozdzik, Jolanta Salamonowicz, Malgorzata Styczynski, Jan Zajac-Spychala, Olga Zaucha-Prazmo, Agnieszka
is schema:about of	named entity 'EPIDEMIOLOGY' named entity 'Prevent' named entity 'Viral' named entity 'ANTIVIRAL DRUGS' named entity 'DO NOT' named entity 'ADOLESCENTS' named entity '80%' named entity 'VIRUS REACTIVATION' named entity 'HEMATOPOIETIC CELL TRANSPLANTATION' named entity 'EPSTEIN' named entity 'VIRAL INFECTIONS' named entity 'RISK FACTORS' named entity 'PREVENT' named entity 'ANALYSIS' named entity 'CHILDREN' named entity 'OUTCOME' named entity 'Epstein-Barr Virus' named entity 'Epidemiology' named entity 'EBV' named entity 'myelitis' named entity 'antivirals' named entity 'RSV' named entity 'artesunate' named entity 'ganciclovir' named entity 'CMV infection' named entity 'EBV' named entity 'HPIV' named entity 'risk factors' named entity 'MSD' named entity 'viral infections' named entity 'serostatus' named entity 'Prophylactic' named entity 'CDV' named entity 'infection' named entity 'viral infection' named entity 'risk factor' named entity 'HHV-6' named entity 'viral infection' named entity 'pediatric' named entity 'Combination therapy' named entity 'risk factor' named entity 'infection' named entity 'rituximab' named entity 'kg 1' named entity 'human metapneumovirus' named entity 'viral infection' named entity 'rituximab' named entity 'EBV' named entity 'CMV disease' named entity 'survival rate' named entity 'MUD' named entity 'encephalitis' named entity 'PTLD' named entity 'immunocompromised patients' named entity 'hMPV' named entity 'antiviral drugs' named entity 'seropositivity' named entity 'BKV' named entity 'VZV' named entity 'cidofovir' named entity 'antiviral drugs' named entity 'prophylaxis' named entity 'primary immunodeficiencies' named entity 'CMV' named entity 'probenecid' named entity 'viral infections' named entity 'EBV' named entity 'viral infections' named entity 'MSD' named entity 'EBV' named entity 'HHV-6' named entity 'CMV' named entity 'p-values' named entity 'VZV' named entity 'Bydgoszcz' named entity 'HSV' named entity 'HSV' named entity 'infection' named entity 'epidemiology' named entity 'HHV6' named entity 'Ewing sarcoma' named entity 'viral infection' named entity 'antiviral' named entity 'ECIL' named entity 'BK virus' named entity 'virus' named entity 'plasma' named entity 'urine' named entity 'risk factors'

Attributes

Values

Creator

Bartoszewicz, Natalia
Czyzewski, Krzysztof
Demidowicz, Ewa
Dziedzic, Magdalena
Fraczkiewicz, Jowita
Galazka, Przemyslaw
Gozdzik, Jolanta
Salamonowicz, Malgorzata
Styczynski, Jan
Zajac-Spychala, Olga
Zaucha-Prazmo, Agnieszka

is schema:about of

named entity 'EPIDEMIOLOGY'
named entity 'Prevent'
named entity 'Viral'
named entity 'ANTIVIRAL DRUGS'
named entity 'DO NOT'
named entity 'ADOLESCENTS'
named entity '80%'
named entity 'VIRUS REACTIVATION'
named entity 'HEMATOPOIETIC CELL TRANSPLANTATION'
named entity 'EPSTEIN'
named entity 'VIRAL INFECTIONS'
named entity 'RISK FACTORS'
named entity 'PREVENT'
named entity 'ANALYSIS'
named entity 'CHILDREN'
named entity 'OUTCOME'
named entity 'Epstein-Barr Virus'
named entity 'Epidemiology'
named entity 'EBV'
named entity 'myelitis'
named entity 'antivirals'
named entity 'RSV'
named entity 'artesunate'
named entity 'ganciclovir'
named entity 'CMV infection'
named entity 'EBV'
named entity 'HPIV'
named entity 'risk factors'
named entity 'MSD'
named entity 'viral infections'
named entity 'serostatus'
named entity 'Prophylactic'
named entity 'CDV'
named entity 'infection'
named entity 'viral infection'
named entity 'risk factor'
named entity 'HHV-6'
named entity 'viral infection'
named entity 'pediatric'
named entity 'Combination therapy'
named entity 'risk factor'
named entity 'infection'
named entity 'rituximab'
named entity 'kg 1'
named entity 'human metapneumovirus'
named entity 'viral infection'
named entity 'rituximab'
named entity 'EBV'
named entity 'CMV disease'
named entity 'survival rate'
named entity 'MUD'
named entity 'encephalitis'
named entity 'PTLD'
named entity 'immunocompromised patients'
named entity 'hMPV'
named entity 'antiviral drugs'
named entity 'seropositivity'
named entity 'BKV'
named entity 'VZV'
named entity 'cidofovir'
named entity 'antiviral drugs'
named entity 'prophylaxis'
named entity 'primary immunodeficiencies'
named entity 'CMV'
named entity 'probenecid'
named entity 'viral infections'
named entity 'EBV'
named entity 'viral infections'
named entity 'MSD'
named entity 'EBV'
named entity 'HHV-6'
named entity 'CMV'
named entity 'p-values'
named entity 'VZV'
named entity 'Bydgoszcz'
named entity 'HSV'
named entity 'HSV'
named entity 'infection'
named entity 'epidemiology'
named entity 'HHV6'
named entity 'Ewing sarcoma'
named entity 'viral infection'
named entity 'antiviral'
named entity 'ECIL'
named entity 'BK virus'
named entity 'virus'
named entity 'plasma'
named entity 'urine'
named entity 'risk factors'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software